Gadolinium-based contrast agents as an alternative at vena cavography in patients with renal insufficiency--early experience.
The authors reviewed results of digital subtraction vena cavography with a gadolinium-based contrast agent in 14 patients with serum creatinine levels greater than or equal to 1.5 mg/dL (133 mumol/L). All cavograms were diagnostic. In 11 patients, there was no impairment of renal function. In three patients, a rise in serum creatinine level of greater than or equal to 0.5 mg/dL (44 mumol/L) was attributable to concurrent medical problems. Gadolinium-based contrast agents may be suitable for digital subtraction vena cavography in patients with renal insufficiency.
Kaufman
J A
JA
Division of Vascular Radiology, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA. kaufmanfamily@sprintmail.com
Geller
S C
SC
Bazari
H
H
Waltman
A C
AC
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015901:Angiography, Digital Subtraction; D002245:Carbon Dioxide / Q000009:adverse effects; D003287:Contrast Media / Q000009:adverse effects; D003404:Creatinine / Q000097:blood; D005260:Female; D005682:Gadolinium / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D051437:Renal Insufficiency / Q000000981:diagnostic imaging* / Q000209:etiology; D016306:Vena Cava Filters; D014682:Vena Cava, Inferior / Q000000981:diagnostic imaging*
D003287:Contrast Media; D002245:Carbon Dioxide; D005682:Gadolinium; D003404:Creatinine